Mason Heather J, Serrano-Ikkos Esther, Kamm Michael A
St. Mark's Hospital, Middlesex, London, United Kingdom.
Am J Gastroenterol. 2002 Dec;97(12):3154-9. doi: 10.1111/j.1572-0241.2002.07113.x.
Behavioral techniques, including biofeedback, improve symptoms in a majority of patients with intractable idiopathic constipation. However, it is unknown whether there is also improvement in patients' psychological well-being and quality of life (QOL). It is also unknown whether psychological or QOL factors can be used to predict the response to treatment. We aimed to assess these factors prospectively.
Thirty-one consecutive patients (median age 36 yr) receiving biofeedback retraining for idiopathic constipation were studied. A bowel symptom record, the General Health Questionnaire-28 (GHQ-28) (n = 31) and Hospital Anxiety and Depression Scale (n = 20), both psychological measures, and the Short Form-36 (SF-36) (n = 22), a generic QOL measure, were recorded before and after treatment.
Twenty-two of the patients felt subjectively symptomatically improved. When considering all patients, treatment resulted in decreased depression (p < 0.05), anxiety (p < 0.05), and somatic symptoms (p < 0.01) (psychological measures: GHQ-28), and improved general health (p < 0.05) and vitality (p < 0.05) (QOL measures: SF-36). Patients who improved symptomatically showed significantly higher scores on the GHQ-28 and SF-36, in contrast to the unchanged scores in patients who did not symptomatically improve. Pretreatment GHQ-28 did not predict who would benefit from treatment, but patients in whom pain, emotional problems, or low vitality interfered with daily living (SF-36 pain subscales) were significantly (p < 0.05) less likely to respond to treatment.
The symptomatic improvement produced by biofeedback in constipated patients is associated with improved psychological state and QOL. Some of the psychological morbidity in these patients is reversible. QOL parameters may be useful for predicting a likely response to treatment.
行为技术,包括生物反馈,可改善大多数顽固性特发性便秘患者的症状。然而,患者的心理健康和生活质量(QOL)是否也会改善尚不清楚。心理因素或生活质量因素是否可用于预测治疗反应也不清楚。我们旨在对这些因素进行前瞻性评估。
对31例连续接受特发性便秘生物反馈再训练的患者(中位年龄36岁)进行研究。记录治疗前后的肠道症状记录、心理测量指标一般健康问卷-28(GHQ-28)(n = 31)和医院焦虑抑郁量表(n = 20),以及通用生活质量测量指标简明健康调查问卷(SF-36)(n = 22)。
22例患者主观感觉症状改善。考虑所有患者时,治疗导致抑郁(p < 0.05)、焦虑(p < 0.05)和躯体症状(p < 0.01)(心理测量指标:GHQ-28)减轻,总体健康(p < 0.05)和活力(p < 0.05)(生活质量测量指标:SF-36)改善。症状改善的患者在GHQ-28和SF-36上的得分显著更高,而症状未改善的患者得分不变。治疗前的GHQ-28不能预测谁会从治疗中获益,但疼痛、情绪问题或低活力影响日常生活的患者(SF-36疼痛子量表)对治疗有反应的可能性显著降低(p < 0.05)。
生物反馈对便秘患者产生的症状改善与心理状态和生活质量的改善相关。这些患者的一些心理疾病是可逆的。生活质量参数可能有助于预测对治疗的可能反应。